Solifenacin Succinate Tablet, Film Coated
Product Images NDC 0591-3796

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 3 technical images submitted to the FDA as part of the official labeling for Solifenacin Succinate (NDC 0591-3796). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Actavis Pharma, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Formula (Images 1)

FDA Label Image

5 mg (Images 2)

5 mg (Images 2)
This is a description of Solifenacin Succinate Tablets, which are dispensed by Pharmagst and manufactured in India by Watson Pharma Private Lid. These tablets come in a tight container with 90 film-coated tablets in each and have a usual dosage of once a day. Each tablet contains 5mg of Solifenacin Succinate, and the package insert should be checked for dosage information. They should be stored at a temperature of 20° to 25°C (66 to 77°F) and dispensed as defined in USP guidelines. The LOT/EXP number for these tablets is 2399671.*
FDA Label Image

10 mg (Images 3)

10 mg (Images 3)
Each film-coated tablet contains 10g of Sofenacin Succinate. It is an oral medication with a once-daily dosage. The tablets are to be stored at room temperature and dispensed in a container. The medication is manufactured by Watson Pharma Private Lid in India. A leaflet with information is provided to each patient. This information is for a prescription drug made by Teva Pharmaceuticals in the USA. 90 tablets are contained in a container and the revision date is A712020.*

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.